Community Bank’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$93.9K Hold
476
0.01% 242
2025
Q4
$87.5K Hold
476
0.01% 254
2025
Q3
$73K Buy
+476
New +$72K 0.01% 260
2022
Q4
Sell
-151
Closed -$17K 495
2022
Q3
$17K Buy
+151
New +$19.2K ﹤0.01% 348
2019
Q4
Sell
-119
Closed -$11K 422
2019
Q3
$11K Hold
119
﹤0.01% 351
2019
Q2
$10K Hold
119
﹤0.01% 363
2019
Q1
$10K Hold
119
﹤0.01% 374
2018
Q4
$9K Hold
119
﹤0.01% 369
2018
Q3
$9K Hold
119
﹤0.01% 414
2018
Q2
$8K Hold
119
﹤0.01% 423
2018
Q1
$8K Hold
119
﹤0.01% 442
2017
Q4
$8K Buy
+119
New +$8.03K ﹤0.01% 543

Other funds holding AZN

Community Bank's AZN Position: Q1 2026 in Review

Community Bank held its AstraZeneca (AZN) position steady in Q1 2026 at 476 shares worth $93.9K. The position accounts for 0.01% of the portfolio, ranked #242.

Community Bank first reported a position in AZN in Q4 2017 and has held it in 12 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Community Bank held 476 shares of AstraZeneca worth $93.9K as of Q1 2026.
  • Community Bank left its AstraZeneca share count unchanged in Q1 2026.
  • AstraZeneca made up 0.01% of Community Bank's portfolio in Q1 2026, its #242 holding.
  • Community Bank first reported a position in AstraZeneca in Q4 2017 and has held it in 12 quarters since.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Community Bank's 13F filing for Q1 2026, filed 12 May 2026.